Vivos (RDGL) Other Operating Expenses (2010 - 2025)
Vivos (RDGL) reported Other Operating Expenses of $944913.0 for Q4 2025, up 106.68% on a YoY basis from $457190.0 in Q4 2024, and up 150.32% sequentially from $377484.0 in Q3 2025.
Vivos (RDGL) Other Operating Expenses (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 16 years of Other Operating Expenses data on file, last reported at $944913.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Operating Expenses rose 106.68% year-over-year to $944913.0; the trailing twelve-month figure through Dec 2025 stood at $2.5 million (up 20.72% YoY), and the FY2025 full-year result was $2.5 million, up 20.72% from the prior year.
- Other Operating Expenses climbed to $944913.0 in Q4 2025, from $377484.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $1.7 million in Q2 2021 to a low of $117344.0 in Q4 2021.
- A 5-year average of $525539.2 and a median of $481749.5 in 2023 frame the typical range for Other Operating Expenses.
- Across the five-year window, Other Operating Expenses soared 1839.27% in 2021 and sank 75.81% in 2023, its largest moves.
- Tracing RDGL's Other Operating Expenses over 5 years: stood at $117344.0 in 2021, then soared by 436.82% to $629931.0 in 2022, then fell by 25.59% to $468737.0 in 2023, then dropped by 2.46% to $457190.0 in 2024, then soared by 106.68% to $944913.0 in 2025.
- Business Quant data shows RDGL's Other Operating Expenses at $944913.0 in Q4 2025, $377484.0 in Q3 2025, and $451141.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 944,913.00 |
| Sep 30, 2025 | 377,484.00 |
| Jun 30, 2025 | 451,141.00 |
| Mar 31, 2025 | 682,965.00 |
| Dec 31, 2024 | 457,190.00 |
| Sep 30, 2024 | 712,552.00 |
| Jun 30, 2024 | 370,442.00 |
| Mar 31, 2024 | 494,762.00 |
| Dec 31, 2023 | 468,737.00 |
| Sep 30, 2023 | 582,418.00 |
| Jun 30, 2023 | 680,760.00 |
| Mar 31, 2023 | 156,724.00 |
| Dec 31, 2022 | 629,931.00 |
| Sep 30, 2022 | 161,463.00 |
| Jun 30, 2022 | 591,339.00 |
| Mar 31, 2022 | 647,824.00 |
| Dec 31, 2021 | 117,344.00 |
| Sep 30, 2021 | 120,508.00 |
| Jun 30, 2021 | 1.73 Mn |
| Mar 31, 2021 | 127,555.00 |